| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 4.231 | 64.471 | 56.324 | 23.872 | 23.007 | 11.670 | 35.683 | 56.628 | 58.901 |
| Total Income - EUR | - | 4.231 | 64.640 | 56.436 | 23.889 | 24.358 | 54.127 | 53.943 | 56.634 | 58.913 |
| Total Expenses - EUR | - | 4.324 | 67.239 | 60.049 | 27.444 | 13.335 | 21.635 | 27.776 | 32.300 | 32.568 |
| Gross Profit/Loss - EUR | - | -94 | -2.599 | -3.614 | -3.555 | 11.023 | 32.492 | 26.167 | 24.333 | 26.345 |
| Net Profit/Loss - EUR | - | -136 | -3.246 | -4.178 | -3.794 | 10.791 | 31.950 | 25.628 | 23.767 | 25.433 |
| Employees | - | 1 | 3 | 3 | 2 | 2 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Famagromed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 169 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 7.137 | 6.964 | 4.345 | 995 | 6.828 | 33.590 | 35.264 | 33.731 | 36.973 |
| Inventories | - | 6.100 | 3.498 | 3.453 | 294 | 264 | 185 | 159 | 220 | 261 |
| Receivables | - | 0 | 1.108 | 366 | 355 | 382 | 4.365 | 19.525 | 21.578 | 23.198 |
| Cash | - | 1.036 | 2.358 | 526 | 346 | 6.182 | 29.040 | 15.580 | 11.932 | 13.515 |
| Shareholders Funds | - | -91 | -3.335 | -7.452 | -11.102 | -100 | 7.594 | 33.245 | 31.362 | 32.985 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 7.397 | 10.299 | 11.798 | 12.098 | 6.929 | 25.996 | 2.019 | 2.369 | 3.988 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Famagromed Srl